Immunometabolism in atherosclerotic disorders

Area of Science:

• Immunology
• Cardiovascular Science
• Metabolic Research

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of death.
• Immune cell dysfunction and inflammation are increasingly recognized as key drivers of CVD progression.
• Immune cells respond to environmental cues via immunometabolic networks.

Purpose of the Study:

• To summarize metabolic reprogramming in immune cells during CVD.
• To explore how these metabolic shifts contribute to cellular dysfunction.
• To identify potential therapeutic interventions targeting immunometabolism in CVD.

Main Methods:

• Review of recent scientific literature on immune cell metabolism in CVD.
• Analysis of immunometabolic networks in the context of atherosclerosis and ischemia.
• Synthesis of findings on metabolic adaptations in immune cells and progenitors.

Main Results:

• Immune cells undergo significant metabolic reprogramming in response to CVD-related environmental signals.
• Altered nutrient availability and inflammatory cues synergize to shift immune cell metabolism.
• These metabolic shifts directly influence immune cell function and disease pathology.

Conclusions:

• Metabolic reprogramming of immune cells is central to CVD pathogenesis.
• Targeting these immunometabolic pathways presents a promising therapeutic avenue for CVD.
• Further research into immune cell metabolism can uncover novel strategies to mitigate CVD progression.